Solventum SOLV MedSurg — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Solventum in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solventum's medsurg — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solventum's medsurg — cost of sales?
- Solventum (SOLV) reported medsurg — cost of sales of $622M in Q1 2026.
- How has Solventum's medsurg — cost of sales changed year-over-year?
- Solventum's medsurg — cost of sales increased by 13.5% year-over-year, from $548M to $622M.
- What is the long-term trend for Solventum's medsurg — cost of sales?
- Over 3 years (2022 to 2025), Solventum's medsurg — cost of sales has grown at a 4.9% compound annual growth rate (CAGR), from $2.09B to $2.41B.
- What does medsurg — cost of sales mean?
- The direct costs incurred to produce and deliver the goods sold by the MedSurg segment.
- How do you interpret medsurg — cost of sales?
- Lower costs relative to sales indicate improved manufacturing efficiency and higher gross margins.
- How does medsurg — cost of sales compare across companies?
- Standard cost of goods sold (COGS) metric for manufacturing-based business segments.